Figures & data
Table 1 Demographic Characteristics of Patients and Genotyping of Clinical Strains Resistant and Susceptible to PZA
Table 2 Characteristics of pncA Mutation, PZA Susceptibility and Genotyping in pncA Mutated MDR Strains
Table 3 Concordance of pncA Mutation Detection and PZA Susceptibility by MGIT 960
Figure 1 Pyrazinamidase (PZAse) activity of strains. Red: susceptible to pyrazinamide (PZA) at 100 mg/L; Blue: resistant to PZA at 100 mg/L; Green: resistant to PZA at 300 mg/L. *Mutation type with different phenotype.
![Figure 1 Pyrazinamidase (PZAse) activity of strains. Red: susceptible to pyrazinamide (PZA) at 100 mg/L; Blue: resistant to PZA at 100 mg/L; Green: resistant to PZA at 300 mg/L. *Mutation type with different phenotype.](/cms/asset/275e710d-1a71-4022-a259-2a60d48c9344/didr_a_368444_f0001_c.jpg)